Login / Signup
Chang-Sheng Xu
(Changsheng Xu)
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 3
Top Topics
Left Ventricular
Vascular Smooth Muscle Cells
Poor Prognosis
Angiotensin Ii
Top Venues
Disease markers
Journal of immunology research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Qiu-Fang Ouyang
,
Ying Han
,
Zhi-Hong Lin
,
Hong Xie
,
Chang-Sheng Xu
,
Liang-Di Xie
Corrigendum to "Fluvastatin Upregulates the α 1C Subunit of CaV1.2 Channel Expression in Vascular Smooth Muscle Cells via RhoA and ERK/p38 MAPK Pathways".
Disease markers
2024 (2024)
Qiu-Fang Ouyang
,
Ying Han
,
Zhi-Hong Lin
,
Hong Xie
,
Chang-Sheng Xu
,
Liang-Di Xie
Corrigendum to "Fluvastatin Upregulates the α 1C Subunit of CaV1.2 Channel Expression in Vascular Smooth Muscle Cells via RhoA and ERK/p38 MAPK Pathways".
Disease markers
2024 (2024)
Ying Han
,
Gong Jin
,
Min Pan
,
Zhoufei Fang
,
Dan Lu
,
Wenqin Cai
,
Chang-Sheng Xu
Integrated Bioinformatics and Validation of lncRNA-Mediated ceRNA Network in Myocardial Ischemia/Reperfusion Injury.
Journal of immunology research
2022 (2022)